EdwardDooMD

Gastroenterology • San Francisco, CA

Hepatology & Liver Transplantation

Physician

Join to view full profile

Dr. Doo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Doo's full profile

Already have an account?

Office
1100 Van Ness Avenue
Room 3461
San Francisco, CA 94109
Phone+1 415-600-1020

Fax+1 916-739-0893

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1993 - 1995
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
Weill Cornell MedicineClass of 1990

Certifications & Licensure

CA State Medical License 1993 - 2026
MD State Medical License 1995 - 1996

Clinical Trials

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 Start of enrollment: 2009 Dec 02
Completed
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) Start of enrollment: 2011 Mar 01
Completed
Phase 2
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B Start of enrollment: 2012 Nov 01
Completed
Phase 3
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children Start of enrollment: 2012 Jun 01
Completed
Phase 2, Phase 3
A Nonabsorbable Ileal Apical Sodium-Dependent Bile Acid Transporter Inhibitor for Nonalcoholic Steatohepatitis
Losartan for the Treatment of Pediatric NAFLD Start of enrollment: 2018 Oct 02
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

165 citations
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.
Raj Vuppalanchi, Mohammad S. Siddiqui, Mark L. Van Natta, Erin Hallinan, Danielle Brandman
Hepatology. 2018-01-01
321 citations
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Mohammad S. Siddiqui, Raj Vuppalanchi, Mark L. Van Natta, Erin Hallinan, Kris V. Kowdley
Clinical Gastroenterology and Hepatology. 2019-01-01
62 citations
Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
Samer Gawrieh, Laura A. Wilson, Oscar W. Cummings, Jeanne M. Clark, Rohit Loomba
The American Journal of Gastroenterology. 2019-10-01

Professional Memberships

American Association for the Study of Liver Diseases
Member
European Association for the Study of the Liver
Member